4//SEC Filing
Kalnik Matthew W. 4
Accession 0001455244-10-000069
CIK 0000072444other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 6:28 PM ET
Size
9.1 KB
Accession
0001455244-10-000069
Insider Transaction Report
Form 4
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Transactions
- Sale
Common Stock
2010-03-11$5.95/sh−1,125$6,694→ 39,523.104 total - Exercise/Conversion
Stock Option (Right to Buy)
2010-03-11−1,125→ 14,625 totalExercise: $3.95Exp: 2015-04-01→ Common Stock (1,125 underlying) - Exercise/Conversion
Common Stock
2010-03-11$3.95/sh+1,125$4,444→ 40,648.104 total
Footnotes (2)
- [F1]The acquisition and sale of 1,125 shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The Option will become exercisable in four equal annual installments. The first installment vested on April 1, 2009. The remaining installments vest on April 1, 2010, April 1, 2011 and April 1, 2012.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001459477
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 6:28 PM ET
- Size
- 9.1 KB